SEFAR SOLUTIONS / INNOVATION

Qatar RareAI

Exploring AI-assisted clinical decision support for rare diseases.

The challenge

Rare-disease investigations can involve findings spread across clinical notes, medical history and multiple specialties. RareAI explores how a structured review of this information could help clinicians identify questions that warrant further investigation.

Our direction

The intended platform would organize patient findings and supporting evidence for physician review. Its purpose is to support clinical reasoning; diagnosis and treatment decisions remain the responsibility of qualified clinicians.

Next phase

The proposed next phase will define the clinical scope with qualified collaborators, establish research governance and appropriate data approvals, and evaluate performance against a prespecified protocol. Any clinical deployment would depend on successful validation and applicable approvals.

Research collaboration

We welcome discussions with clinical researchers and healthcare organizations interested in shaping a focused research programme. No clinical institution is represented as a confirmed partner on this page.